Quantitative parameters comparison of 68Ga-FAPI-46 PET/CT and 18F-FDG PET/CT in patients with liver malignancies

Completed

• Conditions: quantitative parameters tumour detection rate; 68Ga-FAPI-46, 18F-FDG, Fibroblast activating protein, Hepatocellular carcinoma, Intrahepatic cholangiocarcinoma, quantitative

• Registration Number: TCTR20210902004
• Lead Sponsor: ational Cyclotron and PET Centre, Chulabhorn Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-06-30
• Study Start: 2021-09-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

patients with diagnosed or suspected liver malignancies who underwent 68Ga-FAPI-46 PET/CT with spot liver PET/MRI and 18F-FDG PET/CT between September 2020 and June 2021

Exclusion Criteria

Secondary malignancy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
quantitative parameters 1 hour after injection Automatic

Secondary Outcome Measures

Name	Time	Method
Detection rate 1 hour after injection Visual analysis